CTM Shares Six Things Every Study Manager Should Know About Clinical Trial Advertising
JERICHO, N.Y., Jan. 24, 2018 /PRNewswire-iReach/ -- Clinical trial advertising is an essential part of patient recruitment and retention. Clinical trial study managers need to have their recruitment protocol and materials approved by an institutional review board (IRB) before they commence advertising and recruiting. Any advertisements, including recruitment scripts and materials, must follow the standards set by an IRB. To assist study managers, CTM shares six tips for successful clinical trial advertising:
1. Direct advertising is an approved means of soliciting participation in clinical trials. In fact, advertising is considered to be the starting point of informed consent and patient selection. Advertisements can be placed in newspapers, on the radio, on TV, and on various digital channels. Clinical research studies can also recruit through posters, flyers, and brochures. Before being distributed, an IRB will need to review the final versions of any advertisements to assess graphics, wording, visual effects, and more for the presence of inappropriate language or coercion. Best practices have provided a structure for clinical trial advertising—ads should only include the information patients need to determine their eligibility and interest in the trial.
2. Clinical trial advertisements must explicitly state that research is being conducted. Using the word research in the headlines of all marketing materials is one of the best methods of informing prospective participants that they are being solicited for research purposes. Being clear and direct with patients sets a bar for patient centricity and transparency throughout the trial.
3. Ensure clinical trial advertisements are devoid of safety claims, drug efficacy statements, and comparative claims between drugs or devices. Pharmaceutical and medical device manufacturers need to be careful to maintain fair balance, meaning that in order to make comparative claims between devices and drugs manufactured by sponsors, additional research studies must be conducted. To properly allocate time and spending resources, safety claims, drug efficacy statements, and comparative claims can be removed from advertising entirely.
4. Although patients can be paid a small stipend to participate, pharmaceutical and medical device companies sponsoring a research study should not consider or advertise payment as a benefit of participation. Make sure all advertisements for a clinical research study avoid language that spins payment as a reward for patient participation.
5. Know your institution's stakeholders and their roles. It's not uncommon for organizations to require study managers to work with public affairs professionals if the trial is likely to generate a lot of attention. Managers of the study should plan to speak with their public affairs office before advertising a clinical trial to maintain a positive public perception.
6. Patient recruitment and retention companies like CTM can help provide maximum ROI from advertising budgets. These firms are experienced in how to create effective clinical trial advertising.
About CTM
CTM is a global clinical trial patient recruitment and retention agency. They have been a top vendor to sponsors, CROs, sites, and other patient recruitment providers since 1995. Clients rely on CTM to determine the most cost-effective ways to recruit and retain patients for clinical studies. They seek out CTM's team of dedicated personnel and unique and effective technology solutions that help accelerate the patient recruitment and retention process. To learn more about CTM, go to http://www.ctmenrolls.com.
Media Contact: Lisa Giosi, fishbat Media, 855-347-4228, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE CTM
iReach LastName, iReachCompany, 111-222-3333, [email protected]
Share this article